Mechanistic studies have shown that IL1RAP function is not restricted to the IL-1 receptor pathway, but also mediates signaling and pro-proliferative effects through FLT3 and c-KIT signaling in AML LSCs (Mitchell et al., 2018). Here, IL1RAP is linked to acute myeloid leukemia.